Area of research
Oncology · Physiology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Nutrition and Health in Aging, Immunotherapy and Immune Responses, and Clinical Nutrition and Gastroenterology.
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities
Abstract CT302: Phase Ia/Ib dose-escalation study of the anti-TIGIT antibody tiragolumab as a single agent and in combination with atezolizumab in patients with advanced solid tumors
Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
Elevated Levels of Proliferating and Recently Migrated Tumor-associated Macrophages Confer Increased Aggressiveness and Worse Outcomes in Breast Cancer